Bromoacetaldehyde dimethyl acetal | CAS:7252-83-7

We serve Bromoacetaldehyde dimethyl acetal CAS:7252-83-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Bromoacetaldehyde dimethyl acetal

Chemical Name:Bromoacetaldehyde dimethyl acetal
CAS.NO:7252-83-7
Synonyms:Bromoacetaldehyde dimethyl acetal
Ethane, 2-bromo-1,1-dimethoxy-
2-bromo-1,1-dimethoxyethane
 
Physical and Chemical Properties:
Density 1.43
Boiling Point 148-150 ºC
Molecular Formula C4H9BrO2
Molecular Weight 169.017
Flash Point 53.9±0.0 °C
 
Specification:
Appearance:Colorless to pale yellow transparent liquid
Assay:≥99.0%
Moisture:≤
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Pharmaceutical intermediates, pesticide intermediates, liquid crystal material intermediates
 



Contact us for information like Bromoacetaldehyde dimethyl acetal chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-bromo-1,1-dimethoxyethane physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-bromo-1,1-dimethoxyethane Use and application,2-bromo-1,1-dimethoxyethane technical grade,usp/ep/jp grade.


Related News: With the continuous accumulation of the API industry and the increasing maturity of the market, competition in China’s API industry will become increasingly fierce.(2-chloro-4-fluorophenyl)methanol manufacturer With the continuous accumulation of the API industry and the increasing maturity of the market, competition in China’s API industry will become increasingly fierce.Methyl 6-fluoro-1H-indole-4-carboxylate supplier With the continuous accumulation of the API industry and the increasing maturity of the market, competition in China’s API industry will become increasingly fierce.2,2,2-Trifluoroethanol vendor “No two studies are the same, and each carries its own unique risks and presents individual challenges, but the aim of CTSuccess is to use the experience we have as a company in supplying materials for thousands of trials to identify the characteristics of a project upfront and highlight potential risk factors that may arise,” said Kristen Devito, Global Director, Catalent Clinical Supply Services.“No two studies are the same, and each carries its own unique risks and presents individual challenges, but the aim of CTSuccess is to use the experience we have as a company in supplying materials for thousands of trials to identify the characteristics of a project upfront and highlight potential risk factors that may arise,” said Kristen Devito, Global Director, Catalent Clinical Supply Services.